Skip to main content
. 2026 Mar 3;13:1731301. doi: 10.3389/fmed.2026.1731301

Table 2.

Summary of key RCTs evaluating liposomal bupivacaine in fascial plane blocks.

Study Design Surgery type Block type Main findings
Hutchins et al. (77) Prospective, RCT, observer-blinded Robotic-assisted hysterectomy Subcostal TAPB (LB vs. bupivacaine) LB significantly reduced opioid consumption at 72 h and lowered maximal pain scores
Hutchins et al. (78) Prospective, RCT, double-blinded Robotic/laparoscopic hysterectomy Subcostal TAPB (LB) vs. port-site infiltration (bupivacaine) LB TAPB reduced 72 h opioid consumption and improved quality of recovery
Turan et al. (79) Multicenter, RCT Major abdominal surgery TAPB (LB) vs. continuous epidural analgesia LB TAPB noninferior for 72 h pain scores; lower hypotension rates; higher opioid consumption
Antony et al. (80). Pilot, RCT, single-blinded Cesarean delivery Surgical TAPB (LB + bupivacaine vs. bupivacaine alone) No significant difference in 48 h MME; trend toward reduced opioid use with LB
Marciniak et al. (81) RCT Minimally invasive thoracic surgery PECS + SAPB (LB + bupivacaine vs. bupivacaine alone) LB did not improve OBAS, reduce opioid use, or decrease pain scores
Hussain et al. (82) Systematic review and meta-analysis of RCTs Abdominal surgery (pooled) Various abdominal FPBs (LB vs. plain LA) Similar analgesic effectiveness between LB and plain LA for abdominal fascial plane blocks

LB, liposomal bupivacaine; TAPB, transversus abdominis plane block; PECS, pectoralis nerve block; SAPB, serratus anterior plane block; FPB, fascial plane block; LA, local anesthetics; MME, morphine milligram equivalents; OBAS, overall benefit of analgesia score.